fbpx

Androgen Deprivation Therapy Slows Prostate Cancer but Causes Heart Disease

Share Button

Heart Disease, Not Cancer, The Leading Cause Of Death Among Prostate Cancer (PCa) Survivors

arteriogram showing coronary arteries of healthy h

My understanding is that in order to become certified medical doctors, all physicians take the Hippocratic Oath vowing to “First do no harm.” If a chemotherapy slows your prostate cancer but causes the death of the patient is the physician causing the patient harm?

The fact is there are many evidence-based, non-toxic, non-conventional therapies that are cytotoxic to PCa. Unfortunately these therapies cannot be patented and sold as therapy. Diet, lifestyle, Supplementation, and more have been show to slow prostate cancer growth just like ADT but without the negative side effects.

I am a long-term cancer survivor and cancer coach. I have remained cancer-free from my “incurable” cancer since 1999 through nutrition, lifestyle, supplementation and more.

To learn more about managing your PCa please scroll down the page, post a question or click the link and go to the cancer coaching page. I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Heart Disease, Not Cancer, The Leading Cause Of Death Among Prostate Cancer Survivors

“What they need to be more concerned with, however, is the possible development of heart disease. A new study authored by Vanderbilt University researchers revealed that heart disease is the most common non-cancer cause of death among prostate cancer survivors…

ADT lowers serum testosterone levels, which is the marker for prostate cancer as it can make the carcinoma grow or shrink more slowly…

Incidentally, the American Heart Association released a report in 2010 about the possible link between ADT and adverse cardiovascular events…

According to the Vanderbilt study, there seems to be an association between ADT and high levels of low-density lipoprotein and triglyceride, decreased lean body mass and increased fat, high insulin resistance and low glucose tolerance, as well as a metabolic state closely similar to metabolic syndrome…

Complications of Androgen Deprivation Therapy in Men With Prostate Cancer

“The standard treatment for men with metastatic PCa is androgen deprivation therapy (ADT). This therapy is associated with a multitude of side effects that can impact quality of life. These include:

  • vasomotor complications (in particular, hot flushes),
  • sexual dysfunction and gynecomastia,
  • osteoporosis,
  • metabolic syndrome, and
  • depression…”

 

Leave a Comment:

7 comments
Add Your Reply